Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Gives Hospitals Extra Year To Look Into Reprocessing Class I SUDs

This article was originally published in The Gray Sheet

Executive Summary

FDA has received nearly 90 510(k)s submission for reprocessing of Class II single-use devices.

You may also be interested in...



Alliance Medical Clears FDA Hurdle For First Of Twenty 510(k)s

Alliance Medical has received 510(k) clearance to reprocess Johnson & Johnson/Ethicon's unipolar laparoscopic/endoscopic instruments, becoming the second major reprocessor to gain FDA sign-off for a reprocessed single use device (SUD)

Alliance Medical Clears FDA Hurdle For First Of Twenty 510(k)s

Alliance Medical has received 510(k) clearance to reprocess Johnson & Johnson/Ethicon's unipolar laparoscopic/endoscopic instruments, becoming the second major reprocessor to gain FDA sign-off for a reprocessed single use device (SUD)

FDA Delays Enforcement For Class III Reprocessed SUDs With Pending PMAs

FDA's reuse policy does not follow precedents set by previous calls for PMAs from original equipment manufacturers, SterilMed argued in a partially successful petition to suspend enforcement actions on Class III device reprocessors.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel